Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma share news and announcements
812 announcements, routine notices left out, newest first. Page 14 of 17.
Jun 2012
May 2012
23 May · Meeting
Equity Share Transfer Books will remain close from July 02, 2012 to July 07, 2012 (both days inclusive), for the purpose of declaration of dividend. Further, the Annual General Meeting will be held on July 07, 2012.11 May · Dividend
Date of payment of dividend on equity shares would be on or after July 7, 2012, subject to approval of the shareholders at the forthcoming Annual General Meeting.
Apr 2012
27 Apr · Dividend
Board of Directors of the Company at its meeting held on April 26, 2012, have recommended dividend @ Rs. 7.50 per equity share of the face value of Rs. 10/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held on July 07, 2012.Further, the Board of Directors of the Company have also approved sub-division of nominal value of equity shares of the Company from Rs. 10/- each to nominal value of Rs. 5/- each, subject to approval of Members at the ensuing Annual General Meeting (AGM) of the Company.16 Apr · Board meeting
To consider and approve, inter alia: (1) The audited Financial Results for the year ended March 31, 2012; (2) Recommending dividend, if any, on equity shares of the Company for the Financial year 2011-12 and (3) Sub-division of shares.
Mar 2012
Feb 2012
Jan 2012
12 Jan · Board meeting
To consider and approve, inter alia, the Unaudited Financial Results for the third quarter ended December 31, 2011.
Dec 2011